231 related articles for article (PubMed ID: 213620)
1. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients.
Chatterjee SN; Fiala M; Weiner J; Stewart JA; Stacey B; Warmer N
JAMA; 1978 Nov; 240(22):2446-9. PubMed ID: 213620
[TBL] [Abstract][Full Text] [Related]
2. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
Merlino C
G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalo and herpes simplex virus infections in renal transplant recipients.
Wertheim P; Slaterus KW; Geelen JL; van der Noordaa J; Wilmink JM
Scand J Urol Nephrol Suppl; 1985; 92():5-8. PubMed ID: 3008317
[TBL] [Abstract][Full Text] [Related]
5. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
6. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
Lowance D; Neumayer HH; Legendre CM; Squifflet JP; Kovarik J; Brennan PJ; Norman D; Mendez R; Keating MR; Coggon GL; Crisp A; Lee IC
N Engl J Med; 1999 May; 340(19):1462-70. PubMed ID: 10320384
[TBL] [Abstract][Full Text] [Related]
7. Viral infections in renal transplant donors and their recipients: a prospective study.
Balfour HH; Slade MS; Kalis JM; Howard RJ; Simmons RL; Najarian JS
Surgery; 1977 May; 81(5):487-92. PubMed ID: 191948
[TBL] [Abstract][Full Text] [Related]
8. The effects of viral infections on renal transplants and their recipients.
Warrell MJ; Chinn I; Morris PJ; Tobin JO
Q J Med; 1980; 49(194):219-31. PubMed ID: 6254109
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
11. Viral infections in renal transplant recipients.
Armstrong JA; Evans AS; Rao N; Ho M
Infect Immun; 1976 Oct; 14(4):970-5. PubMed ID: 186410
[TBL] [Abstract][Full Text] [Related]
12. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
[TBL] [Abstract][Full Text] [Related]
13. Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney.
Pass RF; Long WK; Whitley RJ; Soong SJ; Diethelm AG; Reynolds DW; Alford CA
J Infect Dis; 1978 May; 137(5):556-63. PubMed ID: 207784
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
15. The transplanted kidney as a source of cytomegalovirus infection.
Ho M; Suwansirikul S; Dowling JN; Youngblood LA; Armstrong JA
N Engl J Med; 1975 Nov; 293(22):1109-12. PubMed ID: 171567
[TBL] [Abstract][Full Text] [Related]
16. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
[TBL] [Abstract][Full Text] [Related]
17. Infections in composite tissue allograft recipients.
Hammond SP
Infect Dis Clin North Am; 2013 Jun; 27(2):379-93. PubMed ID: 23714346
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
[TBL] [Abstract][Full Text] [Related]
19. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.
Singh N; Dummer JS; Kusne S; Breinig MK; Armstrong JA; Makowka L; Starzl TE; Ho M
J Infect Dis; 1988 Jul; 158(1):124-31. PubMed ID: 2839576
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
Chatterjee SN; Jordan GW
Transplantation; 1979 Dec; 28(6):457-60. PubMed ID: 229594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
